On Wednesday, January 8, 2025, Cathie Wood-led ARK Invest made significant portfolio adjustments.

The firm sold shares of DraftKings Inc and made notable purchases in Illumina Inc and Intellia Therapeutics Inc.

The DraftKings Trade: ARK Invest, through its ARKF fund, divested a total of 40,801 shares of DraftKings Inc. With shares closing at $38.35, the sale amounted to approximately $1.57 million.

The Illumina Trade: On the same day, ARK Invest increased its stake in Illumina Inc. The ARKG and ARKK funds collectively acquired 9,320 shares, translating to an investment of around $1.3 million, given Illumina’s closing price of $139.68.

This purchase underscores ARK’s confidence in the genomic sequencing market, where Illumina is a leading player.

The Intellia Trade: ARK Invest also made a strategic purchase of Intellia Therapeutics Inc shares. The ARKG and ARKK funds bought a combined total of 100,099 shares, valued at approximately $1.2 million based on the closing price of $12.02. Intellia is known for its advancements in CRISPR gene editing technology, a field ARK has been bullish on due to its potential to revolutionize healthcare.

Other Key Trades:

  • Sold 101,854 shares of Roblox Corp, valued at approximately $6.3 million, reflecting a strategic shift in ARKK’s gaming sector investments.
  • Purchased 653,091 shares of Recursion Pharmaceuticals Inc, totaling about $4.7 million, highlighting continued interest in AI-driven drug discovery.
  • Sold 63,523 shares of Archer Aviation Inc, worth around $666,000, indicating a reevaluation of its position in the urban air mobility market.
  • Bought 608,900 shares of Absci Corp, valued at approximately $2 million, reinforcing ARK’s focus on innovative biotech firms.

Do you want to plan your financial future? Fire Fast by Dzambhala is the right tool for you.

Join the vibrant privacy-ensured Dzambhala community on

#Biotech